Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses
CA 2301964 C · Owner: Gurney, Austin L. · Inventors: Fendly, Brian M.; Carter, Paul J.; Gurney, Austin L.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Various forms of c-mpl agonist antibodies are shown to influence the replication, differentiation or maturation of blood cells especially , megakaryocytes and megakaryocyte progenitor cells. Accordingly these , compounds may be used for treatment of thrombocytopenia.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 21, 1998 and granted February 7, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 21, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 21, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.